- 1. (.+-.)-Noradrenaline
- [precursor of epinephrine; widespread central and autonomic neurotransmitter, principal transmitter of most postganglionic sympathetic fibers; secreted by the adrenal medulla; used pharmacologically as a sympathomimetic. ( CSP )] (UMLS (NCI) C0028351) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine =adrenergic agent;
catecholamine;
Adrenal;
Neurotransmitter;
adrenal medulla hormone;
[AU100] SYMPATHOMIMETICS (ADRENERGICS) =Nordefrin;
(2R,3R)-(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol, 2,3-Dihydoxybutanedioate Monohydrate (1:1) (Salt);
ethylnorepinephrine;
(2R,3R)-(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol, 2,3-Dihydoxybutanedioate Monohydrate (1:1) (Salt) | - 51. No tray
- (UMLS (HL7) C1549519) =Idea or Concept =Tray Type;
|
- 2. 1,9-Nonanedioic Acid
- [A naturally occurring dicarboxylic acid produced by Malassezia furfur andfound in whole grain cereals, rye, barley and animal products. Azelaic acid possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity. Azelaic acid is bactericidal against Proprionibacterium acnes and Staphylococcus epidermidis due to its inhibitory effect on the synthesis of microbial cellular proteins. Azelaic acid exerts its keratolytic and comedolytic effects by reducing the thickness of the stratum corneum and decreasing the number of keratohyalin granules by reducing the amount and distribution of filaggrin in epidermal layers. Azelaic acid also possesses a direct anti-inflammatory effect due to its scavenger activity of free oxygen radical. This drug is used topically to reduce inflammation associated with acne and rosacea. ( NCI )] (UMLS (NCI) C0052761) =Organic Chemical; Pharmacologic Substance =Dicarboxylic Acids;
[DE752] ANTIACNE AGENTS, TOPICAL =AZELAIC ACID 15 %;
AZELAIC ACID 20 %;
| - 52. NO VACCIN-ACUTE ILLNESS
- [ ] (UMLS (ICD9CM) C1561691) Vaccination not carried out because of acute illness;
=Finding |
- 3. 1,9-Nonanediol
- [An aliphatic alcohol (with nine carbon atoms and two hydroxyl groups at positions 1 and 9) used in chemical synthesis and biomedical research. 1,9-Nonanediol suppresses glycine currents in neurons; glycine is a major inhibitory neurotransmitter in the mature mammalian central nervous system. (NCI04) ( NCI )] (UMLS (NCI) C0657542) =Organic Chemical
| - 53. NO VACCIN-ALLERGY TO VAC
- [ ] (UMLS (ICD9CM) C1561694) Vaccination not carried out because of allergy to vaccine or component;
=Finding |
- 4. 19 nortestosterone
- [A synthetic, anabolic steroid analog of testosterone. Similar to testosterone, nortestosterone (19-Nortestosterone) binds to and activates specific nuclear receptors. This agent may be used for testosterone replacement therapy in hypogonadal men, in HIV-wasting syndrome, and in other conditions in order to increase nitrogen retention and fat-free muscle mass. (NCI04) ( NCI )] (UMLS (CSP) C0027368) =Steroid; Pharmacologic Substance; Hormone =Estrenes;
[HS100] ANDROGENS/ANABOLICS =NANDROLONE DECANOATE;
NANDROLONE PHENPROPIONATE;
NANDROLONE DECANOATE;
NANDROLONE PHENPROPIONATE;
| - 54. NO VACCIN-CAREGIV REFUSE
- [ ] (UMLS (ICD9CM) C1561695) Vaccination not carried out because of caregiver refusal;
=Finding |
- 5. No
- (UMLS (HL7) C1546943) =Qualitative Concept =Event Seriousness;
◊ (UMLS (HL7) C1546946) Idea or Concept Event Expected; ◊ (UMLS (HL7) C1546967) Idea or Concept Identity May Be Divulged; ◊ (UMLS (HL7) C1548170) Idea or Concept Release Information; | - 55. NO VACCIN-CHRONC ILLNESS
- [ ] (UMLS (ICD9CM) C1561692) Vaccination not carried out because of chronic illness or condition;
=Finding |
- 6. No
- (UMLS (HL7) C1549056) =Idea or Concept =Expanded yes/no indicator;
◊ (UMLS (HL7) C1549062) Intellectual Product Notify Clergy Code; ◊ (UMLS (HL7) C1549442) Idea or Concept Assignment of Benefits; ◊ (UMLS (HL7) C1549444) Idea or Concept Yes/no indicator; | - 56. NO VACCIN-IMMUNE COMP
- [ ] (UMLS (ICD9CM) C1561693) Vaccination not carried out because of immune compromised state;
=Finding |
- 7. NO
- [A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden. (NCI) ( NCI )] (UMLS (NCI) C0028423) =Geographic Area
| - 57. NO VACCIN-PREV DISEASE
- [ ] (UMLS (ICD9CM) C1561698) Vaccination not carried out because patient had disease being vaccinated against;
=Finding |
- 8. No change
- (UMLS (HL7) C1548568) =Intellectual Product =Action Code;
| - 58. NO VACCINATION NEC
- [ ] (UMLS (ICD9CM) C1561699) Vaccination not carried out for other reason;
=Finding |
- 9. No Charge
- (UMLS (HL7) C1548285) =Idea or Concept =Charge type;
| - 59. NO VACCINATION NOS
- [ ] (UMLS (ICD9CM) C1561690) Vaccination not carried out, unspecified reason;
=Finding |
- 10. No data found
- [No errors, but no data was found matching the query request specification. ( HL7V3.0 )] (UMLS (HL7) C1553410) =Idea or Concept =QueryResponse;
| - 60. NO VACCINATION-PT REFUSE
- [ ] (UMLS (ICD9CM) C1561696) Vaccination not carried out because of patient refusal;
=Finding |
- 11. No data found, no errors
- (UMLS (HL7) C1549779) =Idea or Concept =Query Response Status;
| - 61. NO VACCINATION-RELIGION
- [ ] (UMLS (ICD9CM) C1561697) Vaccination not carried out for religious reasons;
=Finding |
- 12. No Description
- (UMLS (HL7) C1548720) =Intellectual Product =Relational conjunction;
Extended Priority Codes | - 62. no vaccine administered
- (UMLS (HL7) C1548501) =Idea or Concept ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
|
- 13. No Disclosure
- (UMLS (HL7) C1548950) =Idea or Concept =Consent Disclosure Level;
| - 63. No, patient does not have a living will and no information was provided
- (UMLS (HL7) C1548542) =Intellectual Product =Living Will Code;
|
- 14. No disease
- (UMLS (ICPC) C0497153) (No disease; ERITASUN AUSENTZIA; Ingen sygdom; Geen ziekte; EI SAIRAUTTA; Pas de maladie; keine Erkrankung; lelo maxala; sine morbo; Assenza di malattia; INGEN SYKDOM; Sem doenca; Sin enfermedad; FRISK) =Finding =GENERAL AND UNSPECIFIED; Diagnosis/Diseases Component
| - 64. No, patient does not have a living will but information was provided
- (UMLS (HL7) C1548541) =Intellectual Product =Living Will Code;
|
- 15. No edits present on claim
- (UMLS (HL7) C1547446) =Intellectual Product =Overall Claim Disposition Code;
| - 65. No, patient has not agreed to be a donor
- (UMLS (HL7) C1548547) =Intellectual Product =Organ Donor Code;
|
- 16. No encoding - data are displayable ASCII characters.
- (UMLS (HL7) C1548514) =Idea or Concept ;
=Encoding;
| - 66. No, patient is not a documented donor, but information was provided
- (UMLS (HL7) C1548546) =Intellectual Product =Organ Donor Code;
|
- 17. No Evidence of Transfusion Reaction
- (UMLS (HL7) C1549019) =Pathologic Function =Transfusion Adverse Reaction;
| - 67. nobility
- [In Europe and Asia, there are still people with nobility titles (aristocrats). German "von" is generally a nobility title, not a mere voorvoegsel. Others are "Earl of" or "His Majesty King of..." etc. Rarely used nowadays, but some systems do keep track of this. ( HL7V3.0 )] (UMLS (HL7) C1550725) =Idea or Concept =PersonNamePartAffixTypes;
|
- 18. No Exception
- (UMLS (HL7) C1547545) =Idea or Concept =Charge Type Reason;
| - 68. NOC
- [NOC - Nursing Outcome Codes ( HL7V3.0 )] (UMLS (HL7) C1140150) =Intellectual Product =CodeSystem;
|
- 19. NO FAMILY ABLE TO CARE
- [ ] (UMLS (ICD9CM) C0260795) =Finding
| - 69. Nocardia
- [A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for man and animals. ( MSH )] (UMLS (CSP) C0028240) =Bacterium ;
|
- 20. no fat
- [A no fat diet for acute hepatic diseases. ( HL7V3.0 )] (UMLS (HL7) C1550570) =Intellectual Product =Diet;
| - 70. Nocardia asteroides
- [A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man. ( MSH )] (UMLS (CSP) C0028241) =Bacterium ;
|
- 21. No Financial Backing
- [Patient unable to pay and not covered by insurance ( HL7V3.0 )] (UMLS (HL7) C1555022) =Functional Concept =SchedulingActReason;
| - 71. Nocardiaceae
- [family of gram positive, aerobic actinomycetes found in soil and animal tissue; some species are the cause of infection in man and animals. ( CSP )] (UMLS (CSP) C0028243) =Bacterium ;
=Actinomycetales;
|
- 22. No fluid intake for the period specified in the time component of the term
- (UMLS (HL7) C1547098) =Idea or Concept =Nature of challenge;
| - 72. nociceptin
- [an opioid peptide that acts as an endogenous agonist of the opioid receptor-like receptor. ( CSP )] (UMLS (CSP) C0382336) =Amino Acid, Peptide, or Protein; Receptor ;
=endogenous opiate;
|
- 23. No functional limitations
- (UMLS (HL7) C1546410) =Finding =Ambulatory Status;
| - 73. nociception
- [The stimulus-response process involving the stimulation of peripheral pain-carrying nerve fibers (e.g., C-fibers, A-delta fibers) and the transmission of impulses along peripheral nerves of the central nervous system, where the stimulus is perceived as pain. (Taber's) ( NCI )] (UMLS (CSP) C0234194) =Organism Function
|
- 24. No Information
- (UMLS (HL7) C1549058) =Idea or Concept =Expanded yes/no indicator;
| - 74. Nociceptive Reflex
- [A reflex initiated by a painful stimulus. (Taber's) ( NCI )] (UMLS (NCI) C0277847) =Organism Function
|
- 25. No Measurable or Evaluable Disease
- (UMLS (NCI) C0278936) =Finding
| - 75. nociceptor
- [receptor for pain caused by damage to body tissue. ( CSP )] (UMLS (CSP) C0028246) =Body Part, Organ, or Organ Component ;
=neuroreceptor;
|
- 26. NO MED FACILITIES NEC
- [ ] (UMLS (ICD9CM) C0260813) =Finding
| - 76. Noctuidae
- [ ] (UMLS (CSP) C0323288) =Invertebrate
|
- 27. NO MED FACILITIES NOS
- [ ] (UMLS (ICD9CM) C0260814) =Finding
| - 77. NOCTURIA
- [Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS). ( MSH )] (UMLS (ICD9CM) C0028734) =Disease or Syndrome
|
- 28. No order on record for this test. (Used only on queries)
- (UMLS (HL7) C1548297) =Idea or Concept =Result Status;
| - 78. nocturnal focal lobe epilepsy
- [ ] (UMLS (CSP) C1328935) =Disease or Syndrome ;
|
- 29. No payment adjustment
- (UMLS (HL7) C1547512) =Intellectual Product =Payment Adjustment Code;
| - 79. NOD
- [non-obese diabetic mouse; has genetic predisposition to autoimmune diabetes. ( CSP )] (UMLS (NCI) C0085243) =Mammal =laboratory mouse;
|
- 30. NO PROC FOR REASONS NEC
- [ ] (UMLS (ICD9CM) C0260819) =Finding
| - 80. NOD PROSTATE W UR OBST
- [ ] (UMLS (ICD9CM) C1260422) Nodular prostate with urinary obstruction =Disease or Syndrome
|
- 31. NO PROC/CONTRAINDICATION
- [ ] (UMLS (ICD9CM) C0260817) =Finding
| - 81. NOD PROSTATE W/O UR OBST
- [ ] (UMLS (ICD9CM) C1260421) Nodular prostate without urinary obstruction =Disease or Syndrome
|
- 32. NO PROC/PATIENT DECISION
- [ ] (UMLS (ICD9CM) C0260818) =Finding
| - 82. Nodal
- [Of or pertaining to a node, any bulge or swelling of an anatomical structure or part. ( NCI )] (UMLS (NCI) C0443268) =Spatial Concept
|
- 33. No product selection indicated
- (UMLS (HL7) C1549549) =Idea or Concept =Substitution Status;
| - 83. Nodal Arrhythmia
- [An arrhythmia originating from within the atrioventricular node. ( NCI )] (UMLS (NCI) C0264893) =Disease or Syndrome ;
|
- 34. No Publicity
- (UMLS (HL7) C1546839) =Intellectual Product =Publicity Code;
| - 84. Nodal Marginal Zone B-Cell Lymphoma Refractory
- [Nodal marginal zone B-cell lymphoma resistant to treatment ( NCI )] (UMLS (NCI) C0855141) Refractory Nodal Marginal Zone B-Cell Lymphoma;
=Neoplastic Process |
- 35. No range defined, or normal ranges don't apply
- (UMLS (HL7) C1548140) =Qualitative Concept =Abnormal flags;
| - 85. Nodal Marginal Zone B-Cell Lymphoma Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).-2003 ( NCI )] (UMLS (NCI) C0855142) Stage I Nodal Marginal Zone B-Cell Lymphoma;
=Neoplastic Process |
- 36. No record of this patient. (Used only on queries)
- (UMLS (HL7) C1548298) =Idea or Concept =Result Status;
| - 86. Nodal Marginal Zone B-Cell Lymphoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0855143) Stage II Nodal Marginal Zone B-Cell Lymphoma;
=Neoplastic Process |
- 37. No results available; Order canceled.
- (UMLS (HL7) C1548296) =Idea or Concept =Result Status;
| - 87. Nodal Marginal Zone B-Cell Lymphoma Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0855144) Stage III Nodal Marginal Zone B-Cell Lymphoma;
=Neoplastic Process |
- 38. No results available; procedure scheduled, but not done
- (UMLS (HL7) C1548295) =Idea or Concept =Result Status;
| - 88. Nodal Marginal Zone B-Cell Lymphoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0855145) Stage IV Nodal Marginal Zone B-Cell Lymphoma;
=Neoplastic Process |
- 39. No results available; specimen received, procedure incomplete
- (UMLS (HL7) C1548291) =Idea or Concept =Result Status;
| - 89. Nodaviridae
- [A family of RNA viruses infecting insects and fish. There are two genera: Alphanodavirus and Betanodavirus. ( MSH )] (UMLS (CSP) C0599367) =Virus ;
|
- 40. No shock
- (UMLS (HL7) C1550124) =Intellectual Product =Special Handling Code;
| - 90. Node
- [Any bulge or swelling of an anatomical structure or part. ( NCI )] (UMLS (NCI) C0746922) =Body Part, Organ, or Organ Component
|
- 41. no shock
- [Protect against shock ( HL7V3.0 )] (UMLS (HL7) C1550584) =Idea or Concept =EntityHandling;
| - 91. Node of Ranvier
- [constrictions occurring on myelinated nerve fibers at regular intervals of about one millimeter; at these sites the myelin sheath is absent and the axon is enclosed only by Schwann cell processes; Ranvier's nodes allow saltatory conduction, that is, jumping of impulses from node to node, which is faster and more energetically favorable than continuous conduction. ( CSP )] (UMLS (NCI) C0034667) =Body Space or Junction =myelin;
|
- 42. No storage space for message.
- [ Rejection: The message can't be stored by the receiver due to an unspecified internal application issue. The message was neither processed nor stored by the receiving application. ( HL7V3.0 )] (UMLS (HL7) C1699292) =Functional Concept ;
=AcknowledgementDetailCode;
| - 92. node-positive
- [Cancer that has spread to the lymph nodes. ( NCI )] (UMLS (NCI) C0746319) Positive Lymph Node;
=Finding |
- 43. No substitute was dispensed. This is equivalent to the default (null) value.
- (UMLS (HL7) C1549558) =Idea or Concept =Substitution Status;
| - 93. Nodular and Diffuse Pattern
- (UMLS (NCI) C1334973) =Finding
|
- 44. No substitution
- [Substitution is not permitted. ( HL7V3.0 )] (UMLS (HL7) C1552620) =Idea or Concept =SubstitutionCondition;
| - 94. Nodular Basal Cell Carcinoma
- (UMLS (NCI) C1304300) Nodular Basal Cell Carcinoma of Skin;
Nodular Basal Cell Carcinoma of the Skin;
Skin Nodular Basal Cell Carcinoma =Neoplastic Process |
- 45. No suggested values
- (UMLS (HL7) C1547444) =Intellectual Product =Type of Bill Code;
◊ (UMLS (HL7) C1547445) Intellectual Product Revenue code; | - 95. NODULAR CORNEA DEGEN
- [ ] (UMLS (ICD9CM) C0155122) =Disease or Syndrome
|
- 46. No suggested values
- (UMLS (HL7) C1549029) =Idea or Concept =Override reason;
| - 96. NODULAR EPISCLERITIS
- [ ] (UMLS (ICD9CM) C0155352) =Disease or Syndrome ;
|
- 47. No suggested values defined
- (UMLS (HL7) C1549074) =Idea or Concept =Institute;
◊ (UMLS (HL7) C1549612) Idea or Concept Staff type; | - 97. Nodular Fasciitis
- [A rapid growing, non-encapsulated benign neoplasm that arises from the soft tissues. It is characterized by the presence of non-hyperchromatic spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity, in a storiform growth pattern. ( NCI )] (UMLS (NCI) C0410005) =Disease or Syndrome
|
- 48. no table
- (UMLS (HL7) C1550326) =Finding =HL7 Vocabulary Version 2.5;
| - 98. Nodular Hidradenoma
- [A benign epithelial neoplasm arising from the sweat glands. It presents as a nodular lesion usually in the scalp, trunk, and proximal extremities. It is characterized by a nodular growth pattern. Complete excision is curative. ( NCI )] (UMLS (NCI) C1370700) =Neoplastic Process
|
- 49. no table for CE
- (UMLS (HL7) C1547921) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 99. Nodular Lymphoid Hyperplasia of Lung
- (UMLS (NCI) C1334969) =Disease or Syndrome
|
- 50. No tissue expected
- (UMLS (HL7) C1547209) =Intellectual Product =Tissue Type Code;
| - 100. NODULAR LYMPHOMA ABDOM
- (UMLS (ICD9CM) C0153796) =Neoplastic Process
|
home
